Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR-26b-5p

FEBS Letters

Volumn 588, Issue 12, 2014, Pages 2107-2114

  Wu, Tangwei ^a,b   Chen, Weiqun ^a,c   Liu, Shuiyi ^c   Lu, Hongda ^a,c   Wang, Hui ^a   Kong, Deyong ^a   Huang, Xiaodong ^a,c   Kong, Qinzhi ^a,c   Ning, Yong ^a,b   Lu, Zhongxin ^a,c  

^a CENTRAL HOSPITAL OF WUHAN   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c Wuhan Institute of Medical Sciences   (China)

Author keywords

Apoptosis; EZH2; Huaier; Lung cancer; miR 26b 5p; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 26B 5P; NATURAL PRODUCT; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRAMETES; TRAMETES ROBINIOPHILA MURRIS; UPREGULATION;

APOPTOSIS; EZH2; HUAIER; LUNG CANCER; MIR-26B-5P; PROLIFERATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; LUNG NEOPLASMS; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 2; PROTO-ONCOGENE PROTEINS C-BCL-2; TRAMETES; UP-REGULATION;

EID: 84901444226     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.04.044     Document Type: Article

References (34)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J. Clin. 63 1 2013 11 30
2. S. Chen, A. Flower, A. Ritchie, J. Liu, A. Molassiotis, H. Yu, and G. Lewith Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: a systematic review Lung Cancer 68 2 2010 137 145
3. H. Wei, and Z. Yongming Function of traditional Chinese medicine in cancer radiotherapy and its prospect World Sci. Technol. 11 5 2009 742 746
4. L. Li, S. Ye, and Y. Wang Progress on experimental research and clinical application of Trametes robiniophila Bull. Chin. Cancer 2 2007 016
5. Y. Guo, P. Cheng, Y. Chen, X. Zhou, P. Yu, and Y. Li Studies on the constituents of polysaccharide from the hyphae of Trametes robiniophila (II) - identification of polysaccharide from the hyphae of Trametes robiniophila and determination of its molar ratio J. China Pharm. Univ. 23 1992 155 157
6. Y. Guo, P. Cheng, Y. Chen, X. Zhou, P. Yu, and Y. Li Isolation and analysis of the polysaccharide of Huaier mycelium Chin. J. Biochem. Pharm. 63 1993 56 59
7. G. Zhang, Q. Zheng, and Z. Yuan Trametes robiniophila murr induced apoptosis of hepatocellular carcinoma cell Line MHCC97H J. Oncol. 4 2010 011
8. N. Zhang, X. Kong, S. Yan, C. Yuan, and Q. Yang Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis Cancer Sci. 101 11 2010 2375 2383
9. X. Wang, N. Zhang, Q. Huo, and Q. Yang Anti-angiogenic and antitumor activities of Huaier aqueous extract Oncol. Rep. 28 4 2012 1167 1175
10. C. Zhang, Y.L. Chi, P.Y. Wang, Y.Q. Wang, Y.X. Zhang, J. Deng, C.J. Lv, and S.Y. Xie MiR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2 PLoS One 7 10 2012 e46090
11. Y. Huang, Y.B. Yang, X.H. Zhang, X.L. Yu, Z.B. Wang, and X.C. Cheng MicroRNA-21 gene and cancer Med. Oncol. 30 2013 376
12. A. Kozomara, and S. Griffiths-Jones MiRBase: integrating microRNA annotation and deep-sequencing data Nucleic Acids Res. 39 2011 D152 D157
13. Q. Cao, R.S. Mani, B. Ateeq, S.M. Dhanasekaran, I.A. Asangani, J.R. Prensner, J.H. Kim, J.C. Brenner, X. Jing, X. Cao, R. Wang, Y. Li, A. Dahiya, L. Wang, M. Pandhi, R.J. Lonigro, Y.M. Wu, S.A. Tomlins, N. Palanisamy, Z. Qin, J. Yu, C.A. Maher, S. Varambally, and A.M. Chinnaiyan Coordinated regulation of polycomb group complexes through microRNAs in cancer Cancer Cell 20 2 2011 187 199
14. T. Sudo, T. Utsunomiya, K. Mimori, H. Nagahara, K. Ogawa, H. Inoue, S. Wakiyama, H. Fujita, K. Shirouzu, and M. Mori Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma Br. J. Cancer 92 9 2005 1754 1758 (Pubitemid 40756488)
15. H. Wang, S. Liu, G. Liao, and M. Peng Huaier granule combined docetaxel for nonsmall-cell lung cancer in elder patients: a clinical study Eval. Anal. Drug-Use Hosp. China 4 2011 025
16. X. Yan, T. Lyu, N. Jia, Y. Yu, K. Hua, and W. Feng Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3beta/beta-catenin pathway PLoS One 8 5 2013 e63731
17. C.C. Solomides, B.J. Evans, J.M. Navenot, R. Vadigepalli, S.C. Peiper, and Z.X. Wang MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis Acta Cytol. 56 6 2012 645 654
18. X.X. Liu, X.J. Li, B. Zhang, Y.J. Liang, C.X. Zhou, D.X. Cao, M. He, G.Q. Chen, J.R. He, and Q. Zhao MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11 FEBS Lett. 585 9 2011 1363 1367
19. J. Li, X. Kong, J. Zhang, Q. Luo, X. Li, and L. Fang MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer Cancer Cell Int. 13 1 2013 7
20. N. Wu, X. Zhao, M. Liu, H. Liu, W. Yao, Y. Zhang, S. Cao, and X. Lin Role of microRNA-26b in glioma development and its mediated regulation on EphA2 PLoS One 6 1 2011 e16264
21. S. Rizzo, J.M. Hersey, P. Mellor, W. Dai, A. Santos-Silva, D. Liber, L. Luk, I. Titley, C.P. Carden, G. Box, D.L. Hudson, S.B. Kaye, and R. Brown Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2 Mol. Cancer Ther. 10 2 2011 325 335
22. Y.A. Yang, and J. Yu EZH2, an epigenetic driver of prostate cancer Protein Cell 4 5 2013 331 341
23. Huqun, R. Ishikawa, J. Zhang, H. Miyazawa, Y. Goto, Y. Shimizu, K. Hagiwara, and N. Koyama Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer Cancer 118 6 2012 1599 1606
24. R.J. Bryant, N.A. Cross, C.L. Eaton, F.C. Hamdy, and V.T. Cunliffe EZH2 promotes proliferation and invasiveness of prostate cancer cells Prostate 67 5 2007 547 556 (Pubitemid 46536947)
25. M.E. Gonzalez, X. Li, K. Toy, M. DuPrie, M.A.C. Ventura, M. Banerjee, M. Ljungman, S.D. Merajver, and C.G. Kleer Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1 Oncogene 28 6 2009 843 853
26. C.M. Koh, T. Iwata, Q. Zheng, C. Bethel, S. Yegnasubramanian, and A.M. De Marzo Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms Oncotarget 2 9 2011 669 683
27. K. Cai, Y. Wan, G. Sun, L. Shi, X. Bao, and Z. Wang Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells Oncol. Rep. 28 6 2012 2101 2106
28. T. Sakurai, V.N. Bilim, A.V. Ugolkov, K. Yuuki, M. Tsukigi, T. Motoyama, and Y. Tomita The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells Biochem. Biophys. Res. Commun. 422 4 2012 607 614
29. M. Smits, J. Nilsson, S.E. Mir, P.M. van der Stoop, E. Hulleman, J.M. Niers, P.C. de Witt Hamer, V.E. Marquez, J. Cloos, A.M. Krichevsky, D.P. Noske, B.A. Tannous, and T. Würdinger MiR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis Oncotarget 1 8 2010 710 720
30. S. Varambally, Q. Cao, R.S. Mani, S. Shankar, X. Wang, B. Ateeq, B. Laxman, X. Cao, X. Jing, K. Ramnarayanan, J.C. Brenner, J. Yu, J.H. Kim, B. Han, P. Tan, C. Kumar-Sinha, R.J. Lonigro, N. Palanisamy, C.A. Maher, and A.M. Chinnaiyan Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer Science 322 5908 2008 1695 1699
31. Y. Schmitz, K. Rateitschak, and O. Wolkenhauer Analysing the impact of nucleo-cytoplasmic shuttling of beta-catenin and its antagonists APC, Axin and GSK3 on Wnt/beta-catenin signalling Cell. Signal. 25 11 2013 2210 2221
32. A.S. Cheng, S.S. Lau, Y. Chen, Y. Kondo, M.S. Li, H. Feng, A.K. Ching, K.F. Cheung, H.K. Wong, J.H. Tong, H. Jin, K.W. Choy, J. Yu, K.F. To, N. Wong, T.H. Huang, and J.J. Sung EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis Cancer Res. 71 11 2011 4028 4039
33. Y. Guo, L. Ying, Y. Tian, P. Yang, Y. Zhu, Z. Wang, F. Qiu, and J. Lin MiR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling FEBS J. 280 18 2013 4531 4538
34. Q. Li, W.M. Dashwood, X. Zhong, H. Nakagama, and R.H. Dashwood Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving beta-catenin, c-Myc and E2F1 Oncogene 26 42 2007 6194 6202 (Pubitemid 47414373)